TCRT Insider Trading Activity and SEC Form 4 Filings
TCRT insider trading summary
No open-market insider purchases or sales of Alaunos Therapeutics, Inc. (TCRT) have been reported on SEC Form 4 in the past 12 months.
Latest TCRT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 31, 2024 | Jaime Vieser | Insider | Sell | $4K (2,182 @ $2.01) |
| Dec 31, 2024 | Jaime Vieser | Insider | Sell | $2K (818 @ $2.00) |
| Sep 1, 2023 | Kevin S. Boyle Sr. | Chief Executive Officer | Sell | $10K (68,014 @ $0.14) |
| Nov 29, 2022 | Jaime Vieser | Director | Buy | $813K (1,250,000 @ $0.65) |
| Nov 29, 2022 | Robert W Postma | Director | Buy | $488K (750,000 @ $0.65) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.